Weekly injections of the weight-loss drug, Wegovy, reduce the risk of COVID-related death and overall mortality in overweight patients with heart disease. | Drug Discovery And Development ...
A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.